Now, Developer

Jan 13, 2020

23andMe has licensed an antibody it developed to treat inflammatory diseases to the Spanish drugmaker Almirall, according to Bloomberg.

"This is a seminal moment for 23andMe," Emily Drabant Conley, the vice president of business development at 23andMe, tells Bloomberg. "We've now gone from database to discovery to developing a drug."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

CMS Letter to Orig3n

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

And After the Test

In an editorial at BMJ Opinion, two genetic counselors call for an increased focus on post-test patient care.

Faster, But Not Fast Enough

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

PLOS Papers on Plasmodium vivax Variation in Ethiopia, Childhood BMI Loci, More

In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.

Menu

Now, Developer

To read the full story....

Breaking News

Congenital Hydrocephalus Exome Study Reveals Mutations in Early Brain Development Genes

PathogenDx Partners With Prevenio on Food Safety System

CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon

Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test

The Scan

CMS Letter to Orig3n

And After the Test

Faster, But Not Fast Enough

PLOS Papers on Plasmodium vivax Variation in Ethiopia, Childhood BMI Loci, More

What's Popular?

CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon

10x Genomics Acquisitions Point Towards New In Situ Analyisis Platform

LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test

Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

Pacific Biosciences, Children's Mercy, Microsoft Collaborate on Rare Genetic Disease Diagnostics

Sponsorships